SCHEMBL8934619

SCHEMBL8934619

O=c1c(O)ccc2oc(-c3cc(O)c(O)c(O)c3)c(O)c(O)c1-2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 8/20 0.47
▸ KMT2A Q03164 8/20 0.47
▸ RECQL P46063 6/20 0.47
▸ CD38 P28907 4/20 0.47
▸ ABCC1 P33527 3/20 0.47
▸ TDP1 Q9NUW8 3/20 0.47
▸ MAPK8 P45983 2/20 0.46
▸ KDM4E B2RXH2 6/20 0.44
▸ ALOX15 P16050 6/20 0.44
▸ MAPT P10636 5/20 0.44
▸ CYP3A4 P08684 5/20 0.44
▸ CYP2C9 P11712 5/20 0.44
▸ HSD17B10 Q99714 5/20 0.44
▸ SLCO2B1 O94956 4/20 0.44
▸ ALDH1A1 P00352 4/20 0.44
▸ AMY1A P0DUB6 4/20 0.44
▸ HPGD P15428 4/20 0.44
▸ APEX1 P27695 4/20 0.44
▸ ALOX12 P18054 4/20 0.44
▸ FTO Q9C0B1 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL219729 0.70 BCL9 (0.49) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL1880963 0.69 MEN1 (0.66) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL12639988 0.68 MEN1 (0.61) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL29574854 0.67 MEN1 (0.42) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL3066182 0.65 MEN1 (0.78) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL12639983 0.65 MEN1 (0.74) MEN1KMT2ARECQLCD38ABCC1
Robinetin SCHEMBL217743 0.64 MEN1 (1.00) MEN1KMT2ARECQLCD38ABCC1
Robinetin SCHEMBL29883566 0.64 MEN1 (1.00) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL12640014 0.63 MEN1 (0.77) MEN1KMT2ARECQLCD38ABCC1
SCHEMBL25926916 0.63 MAPK8 (1.00) MEN1KMT2ARECQLCD38ABCC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO disclosed
Send feedback